---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-051210"
form_type: "8-K"
ticker: "TARA"
cik: "0001359931"
company_name: "Protara Therapeutics, Inc."
filed_at: "2024-06-10T23:59:59+00:00"
generated_at: "2026-06-01T05:15:45.959499+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Protara Therapeutics stockholders approve all five proposals at 2024 Annual Meeting

## Summary
- Class I directors elected: Jane Huang (9.66M for), Richard Levy (9.64M for), Michael Solomon (9.56M for); broker non-votes 3.81M.
- Ratification of Ernst & Young as auditor: 13.40M for, 189,574 against, 1,424 abstentions.
- Advisory vote on exec compensation approved: 7.00M for, 196,457 against, 2.59M abstentions plus broker non-votes.
- 2024 Equity Incentive Plan and 2024 Employee Stock Purchase Plan both approved: 9.60M and 9.65M for, respectively.

## SEC filing metadata
- accession: 0001213900-24-051210
- form_type: 8-K
- ticker: TARA
- cik: 0001359931
- company_name: Protara Therapeutics, Inc.
- filed_at: 2024-06-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1359931/000121390024051210/0001213900-24-051210-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1359931/000121390024051210/ea0207579-8k_protara.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-051210
- JSON: https://secwatch.observer/filing/0001213900-24-051210.json
- Plain text: https://secwatch.observer/filing/0001213900-24-051210.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.